AstraZeneca Pharma Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

AstraZeneca Pharma Company Profile :

AstraZeneca Pharma is an Indian biopharmaceutical company. The Company operates through two segments – Healthcare segment and the Clinical Trial segment.

The Healthcare segment is engaged in the manufacture and sale of pharmaceutical products. The Clinical Trial segment offers clinical trial services on pharmaceutical products. The Company is focused on the therapeutic areas, including anesthetic, cardiovascular, gastrointestinal, infection, maternal healthcare, oncology and respiratory.


Astrazeneca Pharma India ResultsBSE Code : 506820
NSE Symbol : ASTRAZEN
ISIN No. : INE203A01020
Industry : Pharmaceuticals
Face Value : Rs. 2.00


If you are an investor who has shares of Astrazeneca Pharma India or you are an stock market analyst then i am sure you might for Quarterly Results of Astrazeneca Pharma India.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Astrazeneca Pharma India. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Astrazeneca Pharma India.

Astrazeneca Pharma India Q1 Results 2016-17 :

Astrazeneca Pharma India will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Astrazeneca Pharma India will announce its Q2 FY 2016-17 Results in the month of October 2017.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Astrazeneca Pharma India will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Astrazeneca Pharma India will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Astrazeneca Pharma India will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Astrazeneca Pharma India Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue  563.73
Other Income  6.77
Total Income  570.51
Expenditure  -547.32
Interest  –
Depreciation  -17.43
PBT  5.76
Tax  -0.51
Net Profit  5.26
Equity  5.00
EPS  2.10

Note : If you like this information about Astrazeneca Pharma India Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.